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Patient satisfaction with two different models of cancer genetic
services in south-east Scotland
S Holloway1, M Porteous1, R Cetnarskyj1,2, E Anderson3,4, R Rush5, A Fry5, D Gorman6, M Steel7
and H Campbell*,2
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Public Health Sciences, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK; 3Edinburgh Breast Unit, Western General
Hospital, Crewe Road South, Edinburgh EH4 2XU, UK; 4SE Scotland Breast Screening Service, Ardmillan House, Ardmillan Terrace, Edinburgh EH11 2SL,
UK; 5Cancer Research UK, Edinburgh Oncology Unit, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK; 6Lothian NHS Board,
Deaconess House, 148 Pleasance, Edinburgh EH8 9RS, UK; 7School of Biology, University of St Andrews, St Andrews, Fife KY16 9TS, UK
There is a need to integrate primary- and secondary-care cancer genetic services, but the most appropriate model of service delivery
remains unclear. This study reports patients’ expectations of breast cancer genetic services and a comparison of their satisfaction with
two service models. In the first model, risk assessment was carried out using mailed family history data. Women estimated as being at
high/moderate risk were offered an appointment at the familial breast cancer clinic, and those at low risk were sent a letter of
reassurance. In the second model, all women were seen by a genetic nurse specialist, who assessed risk, referred high/moderate-risk
women to the above clinic and discharged those at low risk. Over 60% of all women in the study regarded access to breast screening
by mammogram and regular check-ups as very important. This underlines the demand for a multidisciplinary service providing both
clinical genetic and surgical services. Satisfaction was high with both models of service, although significantly lower among women not
at increased cancer risk and thus not offered a clinical check-up and mammography. Increased cancer worry was associated with a
greater expressed need for information and for reassurance through follow-up clinical checks and mammography. Better targeting of
counselling to the expressed concerns and needs of these women is required to improve the service offered. GPs and patients
expressed no clear preference for any specific service location or staffing configuration. The novel community service was less
expensive in terms of both staff and patient costs. The potential to decrease health staff/patient contact time and to employ nurse
practitioners with both clinical genetic and oncology training should be explored further. The rapidly rising demand for these services
suggests that the evaluation of further new models needs to continue to be given priority to guide the development of cancer genetic
services.
British Journal of Cancer (2004) 90, 582–589. doi:10.1038/sj.bjc.6601562 www.bjcancer.com
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Media attention to scientific developments in cancer genetics and
increased public awareness of the potential importance of a family
history of cancer has resulted in a greatly increased demand for
cancer genetic services. These services aim to identify individuals
who have inherited a significantly increased risk of cancer in order
to counsel them about their risks and to offer appropriate risk
management to reduce morbidity and mortality. Genetic counsel-
ling for patients with a family history of cancer has been shown to
result in a more accurate perception of risk (Evans et al, 1994)
without an increase in anxiety (Hopwood et al, 1998). A survey of
22 regional cancer genetic services in the UK in 1998 reported that
the predominant users of these services were women with a family
history of breast cancer (Wonderling et al, 2001). Internationally,
there is a lack of consensus about how best to deliver cancer
genetic services (Steel et al, 1999), and an urgent need for
empirical evidence to inform service development within the
existing healthcare budgets.
A model of cancer genetic services has been proposed (Campbell
et al, 1995, 2003; Fry et al, 2003), whereby genetic nurse specialists
could offer clinics within GP locality areas to carry out
risk assessment, provide counselling for those whose risk
was not significantly increased and mediate referral of those at
higher risk to the specialist service. It was hoped that this
would provide improved support to primary care and better
services for those not at increased risk, while encouraging
more cost-effective use of specialist resources for those
at increased risk of developing breast cancer. We have previously
reported that the establishment of community-based clinics
leads to substantially higher rates of annual referral, less evidence
of inequity of access due to deprivation and improved referral
practices (Campbell et al, 2003), but not to improved
patient outcomes (Fry et al, 2003). In this study, we report
women’s expectations of cancer genetic services and the results of
a trial assessing women’s satisfaction with this new model of
service.
Received 25 September 2003; revised 11 November 2003; accepted 11
November 2003
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MATERIALS AND METHODS
Participants
Ethical approval for the study was obtained from the local ethics
committee. An invitation to take part in the trial was sent to all
general practices in Lothian (n¼ 125), south-west Fife (n¼ 54) and
Borders (n¼ 24) Health Boards in south-east Scotland. In all, 179
practices (84%) agreed to take part, 23 (11%) declined and 10 (5%)
did not reply. This meant that 725 of the 828 (88%) GPs in practice
across these three Health Boards agreed to refer patients into the
trial. Practices were randomly assigned to either arm of the trial
using a minimisation technique (Pocock, 1983, pp 84– 86) to
ensure that the two groups were balanced for: size of practice;
historical referral rate; and social deprivation index.
During the period March 1998 to November 1999, any woman
referred from participating GP practices to the regional clinical
genetics department for breast cancer genetic risk counselling was
invited to take part in the trial. To be eligible for the trial, women
had to live in the region, be able to give informed consent and to
complete a baseline questionnaire. Women who were symptomatic
or had been diagnosed with breast and/or ovarian cancer were
excluded from the trial as were those who had previously consulted
another clinic about their family history of cancer. Those who were
ineligible to participate were offered the standard regional service.
Procedures
The service offered to women who returned a consent form and a
completed baseline questionnaire was dependent on the arm of the
trial to which their GP practice had been randomised. Details of
the trial procedures have been described in detail (Campbell et al,
2003; Fry et al, 2003), but briefly the trial groups were:
Standard (regional) service Women were sent a family history
form to complete. The family history form requested information
about first-, second- and third-degree relatives. If the family
history form was not returned, a letter was sent to the woman and
to her GP to explain that no consultation was possible without this
information. The genetic nurse specialist drew a pedigree from the
information on the family history form, then assigned categorical
risk assessments together with a genetics consultant using the
criteria published by the Cancer Research Campaign (Cancer
Research Campaign, 1997). If necessary, further information and/
or confirmation of relatives’ diagnoses were obtained from the
cancer registry. When a woman was assessed as not being at a
significantly increased risk (i.e. ‘low’ risk), she and her GP were
sent a letter to explain this. An appointment at the familial breast
cancer clinic was offered to women assessed as being at ‘moderate’
or ‘high risk’, and those for whom an adequate risk assessment
could not be made from the information available. The clinic
consultation offered more detailed discussion with a genetics
consultant about risk status and with a specialist breast surgeon
about options for risk management. Clinical breast examination
and mammography (where appropriate) were carried out at this
visit. After this appointment, the patient’s GP was sent a letter to
summarise the issues discussed. All women were asked to
complete a postal follow-up questionnaire 4 weeks and 6 months
later.
Novel (community-based) service All women in this arm of the
trial were sent an initial appointment for one of the community-
based clinics (held in a GP practice near to where they lived), run
by a genetic nurse specialist. At the clinic, the genetic nurse
specialist ascertained the woman’s family history of cancer and
compiled a family tree. This information was compared to the
criteria published by the Cancer Research Campaign (Cancer
Research Campaign, 1997) to determine whether she was at a
significantly increased risk. When an adequate risk assessment
could not be made during the appointment, further information
and/or confirmation of relatives’ diagnoses were obtained from the
patient, medical records or the cancer registry before the patient
was informed of their risk by letter. Women deemed not to be at a
significantly increased risk (i.e. in the ‘low-risk’ category) were
offered information and reassurance and were discharged from the
clinic. These women and their GPs were sent a letter reaffirming
their ‘low-risk’ status and summarising the issues discussed at the
appointment. The women were asked to complete a postal
questionnaire 4 weeks and 6 months later. Women found to be
at increased risk (i.e. in the ‘moderate-risk’ or ‘high-risk’
categories) were offered an appointment at the regional centre
with a consultant breast surgeon and a genetic nurse specialist.
Prior to this consultation, they were sent a questionnaire asking for
their opinions of the community clinic appointment and what
further information or services they wished from the regional
clinic. They were asked to complete a postal follow-up ques-
tionnaire 4 weeks and 6 months after their clinic appointments.
Sociodemographic and objective breast cancer risk data
Women were asked to record their date of birth, marital status and
educational level on the baseline questionnaire. Information was
also requested on mode of referral, knowledge of breast cancer and
its inheritance, psychological status and details of what services
and information was sought from the consultation. Information
about the category of breast cancer risk to which each woman had
been assigned was derived from the clinical records.
Data relating to the consultation
Clinic data The details of all clinic consultations were recorded.
These included duration of consultation, level of risk stated,
matters discussed, time spent in various clinic activities and
outcome of the consultation. Matters discussed at the consultation
were classified under five headings (family history and genetics;
examination and screening; healthy lifestyles; other matters related
to breast cancer and other matters unrelated to breast cancer).
Satisfaction with services received At the 4-week and 6-month
follow-up, satisfaction with the consultations was measured in
several ways. To assess general satisfaction, women were asked to
assess a number of items from the Medical Interview Satisfaction
Scale (MISS) (Wolf et al, 1978; used with permission from the
author). We used 17 of the 26 original questions in the three
subscales. The psychometric properties of this scale have been
investigated in surveys in general practice with a conclusion that
the MISS represents ‘a valid and reliable instrument for the
assessment of patient satisfaction with individual consultations in
British general practice’ (Meakin and Weinmann, 2002). Satisfac-
tion with three aspects of a consultation were measured:
K The affective aspect (A): The extent to which the respondent
feels the medical professional (MP) listens, understands and is
interested.
K The behavioural aspect (B): The respondent’s evaluation of the
MP’s competence in the consultation.
K The cognitive aspect (C): Satisfaction with the amount and
quality of information provided by the MP.
Each item on the scale was rated on a five-point scale of
agreement from strongly agree (5) to strongly disagree (1). The
summed scores were divided by the number of items answered by
the subject to give mean scores for each aspect of the consultation
and an overall mean score. An evaluation of the subscales within
UK general practice has shown that they represent fairly discrete
but overlapping aspects of satisfaction (Meakin and Weinmann,
2002).
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We also investigated patients’ assessment of the helpfulness of
the specific information given and services offered at the
consultation. We asked what additional information/services
women would have wished to receive and what further action
they had taken since their attendance at the clinic. We also asked
about their preferences with respect to the clinic location and
staffing.
Other measures Psychological distress and cancer worry were
measured at baseline by the General Health Questionnaire (GHQ
30) (Goldberg and Williams, 1988) and the Cancer Worry Scale
(Watson et al, 1998) as described by Fry et al (2003).
Relative cost of operating novel and standard service clinics
(a) Estimate of staff costs:
We estimated staff time taken for various aspects of the
consultation (such as pedigree drawing, risk assessment and
counselling) and travel time to clinics by asking the staff to
complete a standard form recording these details. We also
recorded details of women’s attendance and nonattendance at
clinics. Relative costs were based on a medical salary being two
times that of a clinical genetic nurse specialist (consultant or
associate specialist annual salary of d50 000 and clinical genetic
nurse specialist salary of d25 ,000). The estimates also assumed
that secretarial and administrative staff costs for the novel and
standard service models were approximately equal, with the
support for additional clinics in the novel service being offset by
that for obtaining family history forms from all patients and the
higher nonattendance rate in the standard service. A further
assumption was that the efficiency of staff use within the clinics
could be made approximately equal in the two service models by
appropriate management of clinic sizes and appointments.
(b) Estimate of patient time and financial costs:
Patients were asked to complete a short questionnaire after
clinic appointments asking them to give details of how they
reached the clinic, their travel time and costs, details of any other
costs (such as child care) and any loss of earnings and details of
normal activities interrupted by the appointment.
RESULTS
Participants
Figure 1 shows the progress of participants through each arm of
the trial with respect to the completion of questionnaires described
in this report.
Baseline Over the study period, 374 women consented to take
part in the trial and completed a baseline questionnaire. The age of
the women ranged from 17.5– 69.6 years with a mean (7s.d.) of
38.579.5 years. The characteristics of these women are described
in a related publication (Fry et al, 2003). There were no differences
in age, sociodemographic or educational factors between the two
trial groups (Fry et al, 2003).
Follow-up The completion rates for the follow-up questionnaires
are presented in Figure 1. A total of 274 (73%) completed 4-week
and 265 (71%) women completed 6-month follow-up question-
naires. There were no significant differences between the ques-
tionnaire completion rates in the two arms of the trial.
Clinic consultations
Information was recorded on 379 clinic consultations. The genetics
of breast cancer, the significance of the family history and the
patient’s own risk were discussed in almost all first consultations.
In a large proportion (45– 86%) of these consultations, there was
also discussion of risks to children and other relatives and the
possibility of finding a cancer predisposing gene. Mammography
was discussed in almost all consultations. Screening for other
cancers was much more likely to be discussed by the doctors
seeing women who received the standard (regional) service. Breast
self-examination and adoption of healthy lifestyles were more
likely to be discussed by the nurse at the community clinic (novel
service).
The length of time in minutes spent on each part of the
consultation was not normally distributed in any of the consulta-
tion groups. The median total consultation time was 41 min for the
community clinic appointment and 12 min for the regional follow-
up appointment as part of the novel service; and 18 min for the
regional appointment of the standard service. Women receiving
the novel service spent more time at their initial community clinic
appointment discussing each of the five areas of consultation (see
above) than those receiving the standard service (Po0.01 to 0.001,
Mann– Whitney test). Some of the increased time taken by the
novel service was due to the fact that details of the family history
had to be obtained at the community clinic appointment rather
than by questionnaire as in the standard service.
Choice of clinic location and personnel At the 4-week follow-up,
107 (96%) women were satisfied with the length of community
clinic appointment and 89–93% of women with that at the regional
clinic. In all, 69 (30%) women did not state any strong preference
for the location of a familial breast cancer clinic run by specially
trained staff. There was a tendency for women to prefer the
location of the clinic they had attended. The most popular choices
were for a community clinic (selected by 27 (52%) of low-risk
women who had received the novel service) and a regional clinic
(selected by 51 (42%) women who received the standard service).
Among the women who had attended both community and
regional clinics, 23 (38%) preferred a community clinic and 16
(27%) a regional clinic. Overall, 115 (50%) of the women expressed
no strong preference on the grade and type of staff and 58 (25%)
preferred a genetic nurse and a consultant breast surgeon.
Expectations of the breast cancer family clinic
Information needs In all, 294 (79%) women said that they would
like as much information as possible about their family history of
cancer, but a minority of 35 (9%) wanted general information only
and 43 (12%) only wished to know if their family was at increased
risk. Women in the first group had significantly (Po0.05) higher
cancer worry scores than women in the other two groups
combined (Mann–Whitney test).
Women were asked to rate how important it was for them to get
information about various specific issues. Items of information
regarded by over 70% of women as very important are given in
Table 1. Women less than 40 years attached greater importance to
getting information about their risk than did older women
(Po0.01).
Access to specific services Services for which access was regarded
as very important by over 60% of women are given in Table 1.
Women who placed great importance on the need for services to
check their current cancer risk (those who rated the need for
breast examination, check for current signs of cancer and
mammography as very important) showed no difference in
objective cancer risk or anxiety levels compared to those who
did not. However, these women exhibited significantly greater
cancer worry (Po0.01, Mann–Whitney test).
Assessment of services received
Patient satisfaction with services: overall satisfaction Table 2
summarises the median patient satisfaction scores by MISS
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subscale and trial group. There were no significant differences by
trial group.
Table 3 details the views of patients on specific aspects of
satisfaction with services at the 4-week follow-up. The items are
listed together with the aspect of the consultation measured and
the number and percentage of patients who agreed/strongly
(dis)agreed with the statement. A single satisfaction score was
constructed as the mean of scores of all 17 questions. Most women
were satisfied with the consultations in both models of service,
with responses heavily skewed towards the ‘satisfied’ responses.
When we considered factors that may have influenced satisfaction,
no statistically significant correlation (Spearman rank correlation)
was found between overall score and cancer worry (Cancer Worry
score), anxiety (GHQ score), age or deprivation score. There was
no significant difference between satisfaction in different educa-
tional groups (ANOVA). However, women assessed as ‘low’ risk
were less satisfied with the services they received (Po0.05, t-test)
than those assessed at ‘moderate’ or ‘high’ risk, as defined in this
study.
Patient satisfaction with services: satisfaction subscales (see
Table 3) The scores for the affective, behavioural and cognitive
subscales in the MISS were not significantly correlated (Spearman
rank correlation) with cancer worry (Cancer Worry score), anxiety
(GHQ score) or age. There was no significant difference between
educational groups in any of these scores (Kruskal– Wallis test).
However, women at ‘low’ risk of breast cancer gave significantly
lower mean scores for the affective (listening, understanding and
interest of health staff) and cognitive (amount and quality of
information given), but not the behavioural (competence of health
staff) components of the satisfaction questionnaire (Po0.05,
Mann– Whitney test).
Additional services requested by women A greater proportion of
women who received the novel community service stated at the 4-
week and 6-month follow-up that they would have liked additional
services (Table 4). However, this is confounded by the higher
proportion of women scored as low risk in the novel service trial
group. Overall, in both trial groups 37% (24 of the 65) low-risk
women wished access to other services. Low-risk women receiving
the novel service noted mammography, breast examination,
regular check-ups and screening for other cancers most com-
monly. Eight (19%) of these women at 4 weeks and seven (17%)
women at 6 months wanted access to mammography. High- and
moderate-risk women receiving the standard service most
commonly noted screening for other cancers and genetic testing.
At the 4-week follow-up, women who wanted further appointments
to check their breast cancer status had higher cancer worry scores
than other women (Po0.05, Mann– Whitney test).
Further action since attending clinic(s) Table 5 shows the number
(%) of women (who completed both the 4-week and 6-month
questionnaires) who stated that they intended to seek and
had sought further advice about their family history of
cancer after their clinic appointments. Overall, 42 (20%) stated
that they intended to seek further advice and 18 (9%) actually
sought further advice within 6 months. Most women simply
wanted to keep up to date with new research or to find out about
matters that they had not asked about at the clinic visits. A higher
proportion of women receiving the standard service than the novel
service (w2 test, Po0.05) and of women at moderate or high risk
than low risk (w2 test, Po0.05) stated that they intended seeking
such advice.
Women receiving standard service who did not attend a
clinic but received a letter only
Women in the standard service group who were assessed at low
risk were not offered a clinic appointment but were sent a letter
explaining that they were not at increased risk of breast cancer.
Some 22 (73%) of these women returned a questionnaire at 4-week
and at 6-month follow-up. Although 15 (68%) found the
information in the letter quite or very helpful, seven (32%) found
it only a little helpful or not at all helpful.
Six (27%) and eight (36%) women, respectively, noted that
there were other items about which they would have liked
information at the 4-week and 6-month follow-up. Seven (33%)
and eight (38%) women stated that they would have preferred
a clinic appointment to a letter at the 4-week and 6-month
follow-up, respectively.
Despite having been informed that their risk was not elevated, a
large proportion of these women wished to have access to services
and particularly breast examination (mentioned by eight (36%) at
the 4-week follow-up and 15 (68%) at the 6-month follow-up) and
mammography (mentioned by 14 (64%) at the 4-week and 15
(68%) at the 6-month follow-up). At the 4-week follow-up, only
five women (23%) stated that they intended to seek further advice
(for a variety of reasons) and by the 6-month follow-up, three
(14%) had actually sought further advice.
Relative cost of operating novel and standard service
clinics
Relative levels of staff costs in the two service models Based on the
duration of appointments, the time taken by staff to carry out
related duties, staff travel times, patient attendance rates and the
assumptions detailed in the methods section, the novel service
Invited to participate (n = 575)
Excluded (n = 201) 
 refused to participate (n = 23) 
 not responded (n = 123) 
 not returned baseline   
  questionnaire (n = 31) 
 administrative reasons (n = 11) 
 protocol violation (n =13)a
4-week follow-up (n = 146) 
 lost to follow-up (n = 8) 
 not returned questionnaire 
  (n = 25) 
 clinical reasons (n = 2)b
 administrative reasons (n =4) 
Consented, completed baseline 
questionnaire and randomised
according to GP practice  
(n = 374)
4-week follow-up (n = 128) 
 lost to follow-up (n = 13) 
 not returned questionnaire 
  (n = 33) 
 clinical reasons (n = 5)b 
 administrative reasons (n =10) 
6-month follow-up (n = 139)  
 not returned questionnaire 
  (n = 34) 
 returned questionnaire blank 
  (n = 1) 
 administrative reasons (n = 1)
6-month follow-up (n = 126) 
 not returned questionnaire
  (n = 38)
 withdrew (n = 4) 
 administrative reasons (n = 3) 
Standard service arm (n = 185) Novel service arm (n = 189)
a For example, the women had received genetic counselling elsewhere or had been treated for cancer.
b for example, investigation of breast symptoms.
Figure 1 Progress of participants through the trial.
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staffing and travel costs were approximately 30% lower than those
for the standard service.
Relative levels of patient costs in the two service models Ques-
tionnaires on time and costs associated with clinic attendance were
completed by 164 patients attending the regional clinic and by 104
patients attending a community clinic. The median travel cost for
attendance at the regional clinic was d1 (interquartile range, d1–
d2.88) and for attendance at a community clinic was d1.00
(interquartile range, d1.00–d1.00). Travel costs were lower for
women travelling to a community clinic (Po0.001, Mann–
Whitney test). The travel time of women attending a community
clinic was also less, with 15% of women taking over 30 min to
reach the clinic compared to 50% of women attending the regional
clinic (Po0.001, w2 test). In addition, only 2% of women attending
a community clinic reported having to arrange care for their
children compared to 12% of women attending the regional clinics.
DISCUSSION
There is widespread recognition of the need to integrate primary-
and secondary/tertiary-care services, but the most appropriate
model of service delivery remains to be defined (Campbell et al,
Table 1 Information and service requirements of patients
Items of information regarded by over 50% of women as very important
The significance of their family history
Their own risk of breast cancer
Anything they can do in everyday life to reduce their cancer risk
How to examine their own breasts
Symptoms of breast cancer to look for
The pros and cons of breast screening
Research to find new or better ways to prevent/detect breast cancer
Breast cancer and its treatment
Services for which access was regarded as very important by over 60% of women
Reassurance that they show no signs of cancer now
Breast screening by mammogram
Regular check-ups
Table 3 Numbers and percentages of women who agreed/strongly agreeda with various statements concerning their appointments
Statement
Aspect of
consultationb
Novel service
(community
clinic) low-risk
women
Novel service
(community clinic)
moderate/high-risk
women
Novel service
(regional clinic)
moderate/high-risk
women
Standard service
(regional clinic)
moderate/high-risk
women
(a) I was told about my risk of developing
cancer in words that I could understand
C 31 (91.2%) 77 (98.7%) 54 (96.4%) 82 (95.3%)
(b) After the consultation I have a good
idea of what changes in my health I should
seek medical advice about.
C 20 (64.6%) 67 (85.9%) 47 (85.5%) 65 (82.3%)
(c) At the consultation I was told all I
wanted to know about my family history of
breast cancer
C 26 (74.3%) 71 (93.5%) 47 (84.0%) 81 (92.0%)
d) The person I saw was very good at
explaining the reasons for any medical tests
which may be necessary
C 22 (81.4%) 67 (95.7%) 48 (88.9%) 76 (93.8%)
e) I feel I understand pretty well the plan for
helping me
C 14 (56.0%) 67 (94.4%) 52 (96.3%) 79 (93.0%)
(f) I was given a chance to say what was
really on my mind
A 30 (88.2%) 64 (90.1%) 46 (86.7%) 74 (85.0%)
(g) I really felt I was understood A 22 (64.7%) 63 (87.5%) 43 (82.7%) 69 (84.2%)
(h) After the consultation I felt much better
about my problems
A 16 (53.3%) 46 (69.7%) 39 (78.0%) 59 (76.6%)
(i) I felt the person I saw really knew how
upset I was about my family history
A 19 (63.3%) 42 (75.0%) 35 (79.5%) 41 (64.0%)
(j) I felt free to talk about private thoughts A 23 (71.9%) 46 (70.8%) 37 (77.1%) 48 (64.0%)
(k) I felt accepted as a person A 32 (91.4%) 64 (91.4%) 50 (92.6%) 74 (93.7%)
(l) I felt that my problems were not taken
seriously
A 24 (75.0%) 63 (92.7%) 43 (89.6%) 79 (96.3%)
(m) All the problems I mentioned were
looked into
B 21 (70.0%) 57 (86.4%) 38 (90.5%) 60 (86.9%)
(n) I felt the person I saw did not spend
enough time with me
B 32 (94.1%) 74 (94.9%) 54 (96.5%) 79 (94.0%)
(o) I was satisfied with the advice I was
given about the courses of action I could
take.
B 19 (59.4%) 75 (97.4%) 49 (90.8%) 75 (88.2%)
(p) The person I saw seemed rushed during
the consultation
B 33 (97.0%) 75 (96.2%) 54 (96.4%) 80 (94.1%)
(q) The person I saw gave me too much
information too quickly
B 30 (85.7%) 69 (88.5%) 49 (87.5%) 82 (94.3%)
aor disagreed/strongly disagreed items l, n, p, q. bA¼ affective aspect (doctor/nurse listens, understands and is interested); B¼ behavioural aspect (doctor/nurse competence);
C¼ cognitive aspect (amount and quality of information provided by doctor/nurse).
Table 2 Median satisfaction subscale scores (with 25th and 75th
percentiles) by trial group (modified MISS)
Patient group
Affective
(A) scale
Behavioural
(B) scale
Cognitive
(C) scale
Novel service: all women 4.0 (3.6–4.3) 4.2 (3.9–4.6) 4.0 (4.0–4.6)
Standard service: all women 4.0 (3.7–4.4) 4.4 (4.0–4.6) 4.0 (4.0–4.8)
MISS¼Medical Interview Satisfaction Scale.
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1995, Donnai et al, 2000). This study reports on a cluster
randomised trial of a novel model of service delivery and presents
patients’ expectations of cancer genetic services and a comparison
of patients’ satisfaction with two service models. Patient satisfac-
tion is both an objective and outcome of care, and is therefore an
important dimension of any consideration of the best configura-
tion of patient services. In addition, satisfied patients are more
likely to comply with advice given, which is an important aspect of
any service in which patient information and advice comprises an
important element of the intervention (Baker, 1991).
Expectations of cancer genetic services
About 80% of women stated that they wanted comprehensive
information about the implications of their family history of
cancer. The items about which women were most concerned to get
information or receive services were those connected with their
own risk and its possible reduction and early detection of breast
cancer. Over 60% of women wanted a breast examination/
mammography to have reassurance that they did not have breast
cancer and regarded access to breast screening by mammogram
and regular check-ups as very important. This underlines the
demand for a multidisciplinary service providing both clinical
genetic and surgical services, as noted by others (Brain et al, 2000).
A recognition that increased cancer worry leads to a greater
expressed need for information and for reassurance from follow-
up checks is also important to guide clinical practice.
Assessment of cancer genetic clinics
Patient satisfaction with services received Levels of satisfaction
with information given, staff attitudes and length of consultation
were high. There were no significant differences between the trial
groups. The lowest levels of satisfaction were found in those
women with levels of cancer risk that were not significantly above
population levels, and who were discharged with reassurance only.
This reinforces the interpretation that many women seek a clinical
examination to allay fears of current cancer (and possibly to have
access to future screening such as mammography). It is also
consistent with the previous finding that genetic counselling has
less impact on general levels of patient satisfaction than other
medical procedures, since it rarely ‘suggests treatment or
eliminates uncertainties’ (Shiloh et al, 1990).
At the 4-week follow-up, 14% of the community clinic (novel
service) group and 25% of the regional clinic (standard service)
group stated that they intended to seek further advice, although the
reasons for this were not primarily due to dissatisfaction with the
service they received. The difference between the two low-risk and
the two moderate/high-risk groups of women in the trial were not
statistically significant. At the 6-month follow-up, only three
women had actually attended another clinic for advice. Thus,
provision of a community service staffed by nurses did not lead to
an increase in the rate of care seeking after the consultation.
Clinic preferences GPs and patients expressed no clear preference
for either model of service. Women who had attended a clinic
consultation were approximately equally divided between expres-
sing preference for a regional clinic, a community clinic and
having no preference. One reason for this may be that many
women are working and so may not find it any easier to get to a
clinic near their home than to the regional clinic. Similarly, about
half of the women had no strong preference when asked for their
choice of clinic personnel. Among those who expressed a
preference, the combination of being seen by a genetic nurse
and consultant breast surgeon was the most popular.
Consultation times were greater when women were seen by a
nurse at a community clinic (novel service). This is largely due to
the time taken to document the woman’s family history, but may
also be because women feel more relaxed talking to a nurse or feel
reluctant to take up the doctor’s time. However, despite the shorter
consultation times at the regional clinics, most women were highly
satisfied with the duration of all consultations.
Management of women with a family history of breast
cancer, but who do not have an increased risk
In all, 36% of women included in the study were not significantly
above population levels of cancer risk. These women were less
satisfied with the service received than women with a higher cancer
risk. Most of these women were satisfied with the consultation.
However, the novel service group was less satisfied than other
groups of women with the amount and quality of information
given. A relationship between patient satisfaction and rating of
comprehension of the information received has been reported
(Kincey et al, 1975), and failure to reassure has been linked to a
failure to provide explanations at women’s level of understanding.
(Grande et al, 2002) It is possible, therefore, that the lower
satisfaction reflects explanation and reassurance that is not
targeted at the major concerns of these women which are a
perceived need for examination for current (and future) cancer
rather than principally a need for information about genetic risk.
There is a need to tailor the explanation/reassurance by health staff
Table 5 Numbers (percentages) of women who intended to and had sought further advice
Patient group Intending to seek further advice Had sought advice
Novel service: all women 14/ 99 (14%) 7/99 (7%)
Novel service; low-risk women (n¼ 42) 5 (12%) 4 (10%)
Novel service; high/moderate-risk women (n¼ 57) 9 (16%) 3 (5%)
Standard service: all women 28/111 (25%) 11/111 (10%)
Standard service; low-risk women (n¼ 8) 0 0
Standard service; high/moderate-risk women (n¼ 103) 28 (27%) 11 (11%)
Table 4 Numbers (percentages) of women who stated that they would
have liked additional services (not offered to them at the clinic
consultation)
Patient group
4-week
follow-up
6-month
follow-up
Novel service: all women 26/115 (23%) 17/114 (15%)
Novel service; low-risk women 19/53 (36%) 11/50 (22%)
Novel service; high/moderate-risk women 7/62 (11%) 6/64 (9%)
Standard service: all women 23/124 (19%) 14/117 (12%)
Standard service; low-risk women 5/12 (42%) 1/8 (13%)
Standard service; high/moderate-risk women 18/112 (16%) 13/109 (12%)
Patient satisfaction with cancer genetic services
S Holloway et al
587
British Journal of Cancer (2004) 90(3), 582 – 589& 2004 Cancer Research UK
C
li
n
ic
a
l
to the background understanding and concerns of these women in
order to improve services for these women.
More than a third of low-risk women who attended the
community but not the regional clinic stated that they wished
access to other services (most often mammography, breast
examination, regular check-ups and screening for other cancers)
at the 4-week follow-up, although this fell to 22% by the time of the
6-month follow-up. Thus, although most low-risk women were
satisfied with being seen by a nurse at a community clinic, many
still preferred to have the choice of accessing other services, even
after being reassured that their risk is low.
Although most of the low-risk women, who received a letter of
reassurance and advice but not a clinic appointment, found the
letter quite or very helpful, about a third found it, at most, only a
little helpful. A similar percentage said there were other items
about which they would have liked information. In all, 50% stated
that they wanted a check that they did not have current cancer,
64% that they wanted mammography and 77% that they wanted
regular check-ups. At the four-week follow-up, 23% of this group
said they intended to seek further advice and at the 6-month
follow-up, 14% had actually done so.
Relative costs associated with the two service models
Since GPs (Campbell et al, 2003) and patients expressed no clear
preference for any specific service location or staffing configura-
tion, cost is likely to be a major determinant of the nature of these
services in the near future. A preliminary comparison of staff time
and travel costs in the two trial groups revealed that the novel
(community) service was associated with approximately 30% lower
staff costs with the assumptions given above. The staff costs of the
novel service could be further reduced if the medium/high-risk
women were referred to a specialist nurse for breast examination/
mammography and did not have a second genetic counselling
consultation (since new issues were rarely raised for discussion at
this second appointment).
The costs of the standard service could be reduced if the
moderate/high-risk patients were assessed at the regional clinic by
nurse practitioners who were dually trained in genetics and
oncology rather than by a medical consultant or associate
specialist staff. This would reduce standard service staff costs to
similar levels to the novel service.
It has been previously shown that being seen by nurses trained
in breast care (including performing breast examinations for
cancer) was acceptable to women and to GPs (Garvican et al,
1998). However, any new service model would first require to be
evaluated with respect to patient outcomes and patient and staff
satisfaction.
Costs to patients in terms of time and money were greater for
attendance at the regional centre. This is consistent with the
evaluations of other specialist outreach services (Bowling et al,
1997). However, since the low-risk patients, who were not offered
an appointment at the regional centre, were the least satisfied it
would appear that these costs were not a major factor influencing
their preference for a particular service.
The potential to decrease nurse/patient contact time could
be explored since shorter consultation times (at regional clinics)
were not associated with lower levels of patient satisfaction
or poorer clinical outcomes. Providing women with written and/or
video information about the process and content of genetic
counselling prior to their clinic attendance may be one way to
achieve this and may in itself contribute to higher levels of patient
satisfaction (Austoker and Ong 1994; Hallowell et al, 1997; Cull
et al, 1998).
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